300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Music
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Art
Manufacturing
FinTech
Finance
Digital Media
Real Estate
Social Media
Financial Services
Franchise
Non Profit
Sporting Goods
Internet
Mobile Advertising
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Belize
Bolivia
Italy
Belarus
Finland
Hungary
Algeria
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Uniservices

VC Fund

Uniservices is a VC fund focused on Health Care and Medical Device. Auckland University's commercialisation arm

Total investments:
36
Last investment:
Lead investor:
6%

Last updated:

Industries Uniservices invests in

Health CareMedical DeviceBiotechnologyManufacturingMedical

Stages Uniservices invests in

SeedVenture - Series UnknownPre-SeedSeries AAngel

Countries Uniservices invests in

New ZealandUnited StatesUnited Kingdom

Round sizes

Seed $694k–$5MPre-Seed $283k–$1.3MVenture - Series Unknown $1.6M–$8.4M

Round size

Seed
$694k–$5M
Pre-Seed
$283k–$1.3M
Venture - Series Unknown
$1.6M–$8.4M

Investment Focus

Industry

  • Health Care 10 (28%)
  • Medical Device 8 (22%)
  • Biotechnology 7 (19%)
  • Manufacturing 7 (19%)
  • Medical 5 (14%)
See all 54 industries →

Stage

  • Seed 23 (64%)
  • Venture - Series Unknown 4 (11%)
  • Pre-Seed 3 (8%)
  • Series A 3 (8%)
  • Angel 1 (3%)

Country

  • New Zealand 26 (72%)
  • United States 4 (11%)
  • United Kingdom 1 (3%)

Investments

CompanyDescriptionRoundLinks
Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices. $2.8M / Seed / Aug 25, 2025
Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space. Seed / Nov 29, 2024
RosterLab goal is to automate every part of the rostering process for healthcare. $1M / Seed / Nov 27, 2024
Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function. $18M / Series A / Oct 28, 2024
Opo Bio develops cell lines for the cultivated meat industry and researchers.They are building a multi-species and multi-cell type product bank for research and commercial usage. They are creating infrastructure that will enable the industry to progress and more effectively scale. Seed / Sep 02, 2024
Acumino offers next-generation, AI powered robot models for the execution of highly dexterous tasks in industrial automation settings. The Acumino AI is trained on the most accurate data of robot interactions and facilitates the deployment of next-generation intelligent robot workers in a fast, scalable, reliable, cost-efficient manner, unlockingunmatched dexterity & ROI. $4M / Venture - Series Unknown / May 01, 2024
TheiaNova provides nonsurgical therapies to patients with vision impairment due to ecstatic vision disorders. A patient suffering from keratoconus will undergo therapeutic remodeling of the cornea with the company's therapy, allowing healthcare professionals to focus on correcting vision impairments with glasses and corrective lenses orhalting progression of the disease with corneal crosslinking. Seed / Feb 03, 2024
Hate & Extremism Insights Aotearoa is a company that develops threat assessment software for international relations and politics. The tool analyzes, monitors, and assesses online behavior and threats and facilitates businesses in simplifying and preventing threats related to hate speech, misogyny, disinformation, extremist ideology, andviolence. Seed / Jan 01, 2024
Gaiatech provides waste-capturing technology services to healthcare companies. As a result of the company's capturing technology for waste anesthetic gas and its tailored surface functionality, healthcare industries can improve removal efficiency and reduce capital and operational costs by selectively removing gases using the capture material. Seed / Dec 01, 2023
ISpy Nits manufacturer develops a biofluorescent powder for treating lice and nits. The company's product kit includes lotion and a non-toxic glow powder that binds to the egg sheath to intensify the effect. As the chemicals interact with bioluminescent proteins, they emit light that is visible to the human eye, identifying lice and their eggsand removing them. Seed / Dec 01, 2023
See all 36 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Music
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Art
Manufacturing
FinTech
Finance
Digital Media
Real Estate
Social Media
Financial Services
Franchise
Non Profit
Sporting Goods
Internet
Mobile Advertising
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Paraguay
Botswana
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Belize
Bolivia
Italy
Belarus
Finland
Hungary
Algeria
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Uniservices invest in?

Uniservices invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Venture - Series Unknown stage. Most of the 36 investments tracked by Shizune back companies in New Zealand. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Uniservices's check size?

Uniservices typically joins rounds of $694k–$5M at Seed, $283k–$1.3M at Pre-Seed and $1.6M–$8.4M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Uniservices participates in.

When did Uniservices last invest?

The most recent investment recorded for Uniservices closed in Aug 2025. Shizune tracks 36 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Uniservices Find emails